 |
|
Advantages of PGT at Fairfax Diagnostics
Experience
- Trusted leader in PGT since 1993
- 25 years of PGT assay design & clinical application
- First laboratory in the world to perform PGT-M for an autosomal dominant disease (Marfan syndrome). The first laboratory in the world to achieve a pregnancy following PGT-M for Spinal Muscular Atrophy Type I (SMA-I)
- Staff professionals certified by the American Board of Medical Genetics in Clinical Cytogenetics, Molecular Genetics, and Clinical Genetics
- Expanded team of molecular geneticists
- Staff of board-certified genetic counselors
- CLIA certified high complexity laboratory
Rapid results
- Available to your physician within 2 business days from recipient of samples
- Open 7 days a week, 365 days a year
Molecular Genetic specialists
- Laboratory Director: Brian D. Mariani, PhD
- Medical Director: Harvey J. Stern, MD. PhD, FACMG
- Assistant Laboratory Director: Veronica Novik, PhD
- PGT project lead & assay validation, Khoa Tran, MS
- Our staff of experienced board-certified genetic counselors is also available for support and assistance with the coordination of your PGT cycle
Technology
- PGT-A using NGS by Illumina’s VeriSeq & Blue Fuse data analysis
- PGT-M incorporating 3 levels of resolution:
- Mutation-specific targeted PCR
- STR haplotype mapping using PCR & CE
- Aneupoildy screening using NGS
- PGT-M assays customized for each couple’s unique genetics
- PGT-SR using NGS as employed for PGT-A
- All PGT approaches can provide gender information for each embryo
Trust
- GIVF maintains a zero misdiagnosis rate in all PGT programs.
- All results reviewed by a team molecular & clinical PhD/MD experts.
- Medical & Laboratory Directors each have over 20 years of experience at Fairfax Dx.
- Genetic Counsellors are involved with all aspects of the PGT program.
|
|
 |